A committee of the Institute of Medicine concludes that the Food and Drug Administration's 510(k) process for approving medical devices deemed to have a moderate risk to patients needs not to be reworked, but replaced.

IOM studied the 510(k) issue at the request of the FDA. The committee was asked to answer two questions:

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access